New Line of Bioinks for 3D Bioprinting
                     New Line of Bioinks for 3D Bioprinting
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery  
products and services, announced the launch of its new line of bioinks for 3D  
bioprinting. The new bioinks are designed to be biocompatible and versatile, making  
them ideal for a wide range of applications, including 3D biological model  
construction and cultivation, tissue engineering, and drug delivery.
CD Bioparticles is dedicated to providing customers with standard and custom  
bioactive matrices in various material forms and compositions that can help  
customers overcome challenges, such as limited selection of crosslinkable  
biomaterials, low consistency of the gelation process leading to uncontrolled  
mechanical properties and crosslink density, and poor control of the purity of the  
biomaterial source. To better support researchers in the bioprinting industry, CD  
BioParticles now introduces a series of new bioinks based on a variety of natural and  
synthetic materials including GelMA, Alginate and HAMA.
For example, the GelMA is a photosensitive hydrogel bioink made from  
methacrylated gelatin (Gel-MA). It is biocompatible (cell viability > 90%), convenient  
to use and has a long structure retention time (more than 30 days). This white  
lyophilized powder retains the temperature-sensitive properties of gelatin and can be  
mixed with photoinitiators (e.g., LAP, 12959) to work under blue or ultraviolet light. It  
is compatible with most human and animal cells, and can be easily printed by mixing  
with cell suspensions. In addition, GelMA has a variety of packaging forms (gel,  
freeze-dried powder) to ensure its high performance.
Another example is the high-purity HAMA, which is synthesized by the reaction of  
hyaluronic acid. The main component of this product is HAMA (methacrylated  
hyaluronic acid, molecular weight 150k-250kDa), which has good biocompatibility  
and can be stimulated by UV light or visible light (blue light) and mixed with basic  
biomaterials or other bio-inks of Shangpu to form a three-dimensional structure with  
a certain intensity suitable for the growth and differentiation of cells.
HAMA can be applied to most human and animal cells and is particularly useful for  
constructing and culturing 3D biological models of joints, cartilage, skin, and cornea.  
It is easy to operate (e.g., fast dissolution, fast cross-linking, fast cross-linking and  
molding in only 10s) and can be customized to meet the specific needs of customers.
CD Bioparticles offers a wide range of unique biomaterial formulations and high  
quality biomaterials, optimized formulations and protocols for customer choice.  
These active biomatrices with controlled mechanical modulus can be used for  
various cell culture and tissue regeneration applications. Meanwhile, the company  
has strict standards for raw material screening and quality control to ensure the  
consistency of biomaterial composition and the accuracy of research results.
For more information, please visit https://www.cd-bioparticles.net/bioinks.
About CD Bioparticles
CD Bioparticles is an established drug delivery company that provides customized  
solutions for developing and manufacturing novel biocompatible drug delivery  
systems. It specializes in various formulation and drug delivery technologies, from  
conventional liposomes and PEGylated liposomes to polymer microspheres and  
nanoparticles for drug delivery. The company also provides contract research  
services for drug delivery formulation, formulation feasibility study, process  
development and scale-up, as well as analytical and non-clinical research services.